Martin Capital Partners, LLC

EUGENE, OR · Quarter end: Sep 30, 2026 · Filed with SEC: Oct 7, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$279.1M2026 Q3
Positions73
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.36.4%

Martin Capital Partners, LLC reported 73 positions worth $279.1M as of September 30, 2026 (13F filed October 7, 2026). Largest holding: AMGN (4.6%). Biggest move: new buy XOM ($8.9M).

10 / 73 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 AMGNAmgen$12.9M4.61%30,552——+9.7%
▸ 2 JNJJohnson & Johnson$11.1M3.96%41,765——+6.7%
▸ 3 CFRCullen/Frost Bankers$10.7M3.84%70,140——+2.2%
▸ 4 CMECme$10.6M3.81%40,624——+21.9%
▸ 5 CVXChevron$10.2M3.64%49,766——+6.3%
▸ 6 MSFTMicrosoft$10.1M3.63%19,736——+1.0%
▸ 7 ASMLAsml$9.5M3.40%5,243——-22.3%
▸ 8 CSCOCisco Systems$9.0M3.21%83,187——-12.2%
▸ 9 XOMExxonMobil$8.9M3.20%54,912——+2.5%
▸ 10 BKHBlack Hills$8.6M3.10%123,316——+23.7%

Pro Feature

The remaining 63 positions with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does Martin Capital Partners, LLC hold as of Q3 2026?

Martin Capital Partners, LLC reported 73 positions worth $279.1M in its Q3 2026 13F filing. Largest positions: AMGN (4.6%), JNJ (4.0%), CFR (3.8%), CME (3.8%) and CVX (3.6%).

What did Martin Capital Partners, LLC buy in Q3 2026?

New positions: XOM and HWC. Added to: CME, ASML, PFE, SPSB and MKC (36 in all).

What did Martin Capital Partners, LLC sell in Q3 2026?

Reduced: PSX, MSFT, CSCO, JPM and TXN (26 in all). Sold out entirely: CAT.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.